secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2026-05-14T21:26:31+00:00
Accession:  0001493152-26-023200
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma raises $4.4M through registered direct offering; plans to spin out AI platform
--------------------------------------------------------------------------------

- Offered 2,135,923 shares at $2.06/share (or pre-funded warrants) plus unregistered warrants for equal shares.
- Unregistered warrants have exercise price $2.27, exercisable after 6 months, expire 5 years from initial exercise.
- Up to additional $4.85M gross proceeds if warrants fully exercised; no assurance of exercise.
- Company plans to separate AI platform withZeta.ai into independent entity; may become publicly listed.
- Suspended ATM sales under July 2025 agreement with ThinkEquity; agreement remains in effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226023200/0001493152-26-023200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226023200/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-023200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer